IGFBP4 and central nervous system cancer: Insulin-like growth factor-binding protein-4 (IGFBP-4) has been found to have anti-angiogenic functions in experiments and can attenuate the aggressiveness of gliomas, and is considered a potential candidate for glioma therapy (163).